Monica Donnelley, PharmD, BCIDP, BCPS, AAHIVP

Assistant Professor, College of Pharmacy

mdonnell@touro.edu

Biography

I am an antimicrobial advisor. My goal is to create customized therapy plans for each patient based on a multitude of factors. Understand that each patient is different from the neonate to someone’s great-grandmother, the gymnast from the linebacker. The world of infectious diseases is fascinating and not only are the patient and the drug involved critical to consider in therapy decisions, but we must also consider the “bug” where did it come from, is it resistant, and can we reach it with our therapy? One of the most rewarding parts of being a pharmacist is education of the future pharmacists. I want to ensure you learn the cutting edge information, build a strong foundation, and be able to build customized plans for your own patients. My research interests include: New agents: antimicrobials and antifungals, antimicrobial dosing in critically ill, improving antimicrobial stewardship services, Outpatient Parenteral Antimicrobial Therapy (OPAT), and reducing C. difficile infections. I keep up in my area of clinical practice by being board certified in infectious diseases and pharmacotherapy, and also certified as an American Association of HIV Pharmacist. Speaking professionally at conferences is also a great way to keep learning.

Education

Doctor of Pharmacy, Touro University, College of Pharmacy
Post-graduate Training: PGY1 Pharmacy Practice Residency, UC Davis Medical Center
PGY2 Infectious Diseases Residency, UC Davis Medical Center

Honors and Awards

2021, Society of Critical Care Medicine
A Presidential Citation for extraordinary contributions of time, energy, and resources during 2020. The Society established the Presidential Citation Award in 1995 to honor SCCM members who have made outstanding contributions to the organization.
2020 Pharmacy Leadership Award – annual award at UC Davis Health in memory of Jeff King
The award recognizes a pharmacist for promoting the role of pharmacists in the health system through leadership and creativity, for mentoring future pharmacy practitioners, and for demonstrating empathy and a sense of humor.
2020, UC Davis Police Department
Certificate of Recognition for partnering with the UC Davis Police Department and Security Teams on COVID-19 infection prevention and education
2018, Research Preceptor of the Year: Residency Class of 2017-2018
University of California Davis Pharmacy Residency Program
2017, Key Note Address
Touro University, College of Pharmacy, White Coat Ceremony
2017, Preceptor of the Year: Residency Class of 2016-2017
University of California Davis Pharmacy Residency Program
2016, Commencement Alumni Address
Touro University, College of Pharmacy, Graduation Ceremony
2015, Antimicrobial Stewardship Pharmacy Team Award, University of California Davis
2012-2013, Professor of the year award for Clinical Sciences Track, Touro University College of Pharmacy

Recent Publications

Gintjee, T, Donnelley, M, Thompson, G. Aspiring Antifungals: Review of Current Antifungal Pipeline Developments. J. Fungi 2020, 6, 28; doi:10.3390/jof6010028

Kobayakawa M, Nguyen K, Tabatabaifar, H, Donnelley, M. Sepsis: Did we treat the bug? Evaluation of a pathogen and source targeted, protocol-driven treatment regimen at a large academic medical center. American Society of Health-System Pharmacist (ASHP) Midyear Meeting, Las Vegas, NV, December 2019.

Cha, M, Dong, J, Wilson, M, Donnelley, M. Outpatient parenteral antimicrobial therapy program expansion: pharmacist interventions by drug type and the impact of post-discharge monitoring. [Poster] Accepted National Meeting Midyear December 2018 Anaheim, CA.

Davis, M, Nguyen, M, Donnelley, M, Thompson, G. Long-Term Tolerability and Efficacy of Fluconazole Therapy. J Antimicrob Chemother. 2019 Mar 1;74(3):768-771. doi: 10.1093/jac/dky501.

Davis, M, Nguyen, M, Donnelley, M, Thompson, G. Long-Term Tolerability and Efficacy of Fluconazole Therapy. Plenary presentation at UC Collaborative Pharmacy Leadership Forum and Presented at National Meeting ID Week [Poster] October 2018.

Kamiyama, D, Ling-Xin C, Donnelley, M, Zhu, E, Clayton, N, Alman, K, Angelo De Mattos, Francalacci, L, Brown, J. Outcomes of Renal Transplants from Donors with Positive Blood and/or Urine Cultures. Plenary Presentation at UC Collaborative Pharmacy Leadership Forum and American Transplant Congress (ATC) [Poster] Presented at National Meeting June 2018, Seattle, WA.

Hoffmann, W, Donnelley, M, Ferguson, T. Susceptibility Trends of Urinary Tract Infections Over a Fifteen Year Period on a University Campus. [Poster] Presented at National Meeting ID Week for October of 2017, San Diego, CA.

Kamiyama, D, Weng B, Donnelley, M, Zhu, E, Brown, J. Use of a Clostridium difficile Risk Calculator to Optimize Antimicrobial Stewardship. [Poster] Presented at National Meeting ID Week for October of 2017, San Diego, CA.

Donnelley, MA, Zhu, ES, Thompson, GR III. Isauconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infect Drug Resist. 2016 Jun 2;9:79-86. Review

Bui, C, Zhu, E., Donnelley, MA, Wilson, M., Morita, M., Cohen, SH., Brown, J. Antimicrobial Stewardship Programs that Target Only High-Cost, Broad-Spectrum Antimicrobials Miss Opportunities to Reduce Clostridium difficile Infections Am J Infect Control. 2016 Dec 1;44(12):1684-1686

Heintz, B, Donnelley, M, Tasaka, C, Duby, J. Vancomycin. Clinical Pharmacokinetics 6th Edition. Book Chapter 22. 2017; 450 pages; Softbound P5365; ISBN: 978-1-58528-536-5 Available On 5/29/2017

Donnelley, M, Heintz, B, Duby, J, Clostridium difficile infection. Pharmacotherapy Principles and Practice Study Guide: A Case Based Care. Book Chapter 4th edition. 2016.

Bui, Christine, PharmD; Zhu, Elizabeth PharmD; Donnelley, Monica PharmD; Wilson, Machelle D PhD; Mora, Margaret BS; Cohen, Stuart H. MD; Brown, Jennifer, MD. Evaluation of Clostridium difficile Infection: Opportunities to Optimize Antimicrobial Stewardship. [Poster] Presented at National Meeting ID Week for October of 2015, San Diego, CA

Heintz, B, Donnelley, M, Duby, J, Clostridium difficile infection. Pharmacotherapy Principles and Practice Study Guide: A Case Based Care. Book Chapter 3rd edition. 2013.

Donnelley, M, Duby, J, Cocanour, C. Safety and Efficacy of Fidaxomicin in Patients with Clostridium Difficile Infection. Clinical Medicine Insights: Therapeutics. 2013:5 75-79. Review Paper. DOI: 10.4137/CMT.S7279.

Donnelley, M, Christensen, C, Heintz, B. Outcomes in patients discharged from an academic medical center on outpatient parenteral antimicrobial therapy (OPAT) following interventions by a multidisciplinary OPAT team. [poster] Presented at National Meeting, Infectious Diseases Society of America October 2012, San Diego, CA

Donnelley, M, Kim, J, Christensen, C, Wiedeman. Benefits of a pediatric antimicrobial stewardship program at a large academic medical center. [poster]. Making a difference in infectious diseases (MAD-ID), Orlando, Fl, 2012

Donnelley, M, Christensen, C, Heintz, B. Feasibility of extended-infusion meropenem and piperacillin-tazobactam and potential cost savings at a large academic institution. [poster]. University HealthSystem Consortium, Anaheim, CA, 2011

Donnelley, M, Christensen, C, Heintz, B. Antibiotic use and duration of therapy in patients with ventilator associated pneumonia at a large academic medical center. [presentation]. Western States Conference, Pacific Grove, CA 2011

Memberships and Affiliations

University of California, Davis Medical Center Pharmacist
Infectious Diseases Specialist
PGY2 Infectious Diseases Residency Program Director

University of California, San Francisco, College of Pharmacy
Assistant Professor of Clinical Sciences

University of California, Davis School of Medicine
Assistant Professor of Clinical Sciences

Get Started Today

Request Info Attend Info Session Apply Now